Defective Drugs
Attorney Chad McLain Discusses Mass Torts on Good Day Tulsa
On Tuesday, April 21st, Attorney Chad McLain of Graves McLain appeared via Skype on KTUL’s Good Day Tulsa program to discuss mass tort lawsuits. Watch the segment: Many people are harmed by dangerous drugs or defective medical devices every year. Sometimes, drugs and medical devices are rushed onto the market without fully taking into account…
Oklahoma Settles Opioid Lawsuit with Teva Pharmaceuticals
Recently, an $85 million settlement between Teva Pharmaceuticals and the state of Oklahoma was signed by Cleveland County District Judge Thad Balkman. The state maintained that Teva utilized deceptive marketing claims to promote opioids as safe and effective pain relievers while de-emphasizing the addictive properties of the drugs. The funds from the settlement are earmarked…
Oklahoma Opioid Lawsuit to be Decided by Judge
A Cleveland County District Judge has ruled he will decide Oklahoma’s case against several drug manufacturers for their alleged complicity in the opioid crisis currently gripping the United States in a bench trial. District Judge Thad Balkman made the decision to forego a jury trial during a recent hearing. An official with the office of…
Opioid Maker Settles $270 Million Oklahoma Lawsuit
Purdue, the manufacturer of the controversial opioid OxyContin, settled a lawsuit brought by the Oklahoma Attorney General for $270 million. A detailed article on the nature of the landmark settlement is available here. A suit filed by Oklahoma Attorney General Mike Hunter against Purdue Pharma alleged the drug manufacturer—through aggressive marketing of OxyContin—fueled the opioid…
FDA Recalls Irbesartan Over Potential Cancer Risk
Another manufacturer has issued recalls for Irbesartan after the frequently prescribed blood-pressure medication tested positive for a probable human carcinogen. A detailed article examining the latest in a series of recalls is available here. According to the United States Food and Drug Administration (FDA), a pharmaceutical manufacturer has recalled multiple lots of Irbesartan. These drugs,…
Losartan Recalled Due to Contamination
Drug manufacturer Camber Pharmaceuticals has issued a recall for large quantities of Losartan. An article on this emerging story is available here. Currently, no patients have reported any adverse effects related to potential contamination. Patients are advised to speak with a qualified physician before discontinuing the drug. The National Drug Code (NDC) numbers associated with…
Valsartan Medications Recalled
Valsartan Medications Recalled Experienced Defective Drug Attorneys Have you suffered from a medicine Injury? Contact Graves McLain for a Free Consultation. Several medications containing the active ingredient Valsartan have been recalled by the United States Food and Drug Administration over contamination issues. The impurity, known as N-nitrosodimethylamine (NDMA), is classified as a probable human carcinogen.…
Risperdal Cases Seek Punitive Damages
Nearly three years ago, two juries in Philadelphia awarded compensatory damages to clients in two lawsuits against Janssen Pharmaceuticals’ drug Risperdal. Now, both cases are proceeding toward new trials to determine punitive damages. A detailed article on the move appears here. Motion to Block Denied Judge Arnold New of the Philadelphia Court of Common Pleas…